false
0000101538
UNITED STATES ANTIMONY CORP
0000101538
2026-01-28
2026-01-28
0000101538
UAMY:CommonStockOneMember
2026-01-28
2026-01-28
0000101538
UAMY:CommonStockTwoMember
2026-01-28
2026-01-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) January 28, 2026
| UNITED STATES ANTIMONY CORPORATION |
| (Exact name of registrant as specified in its charter) |
| Texas |
|
001-08675 |
|
81-0305822 |
|
(State or other jurisdiction
of incorporation) |
|
(Commission
File No.) |
|
(IRS Employer
Identification Number) |
| 4438
W. Lovers Lane, Unit
100, Dallas,
TX |
|
75209 |
| (Address of principal executive officers) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (406) 606-4117
Not Applicable
(Former name or former address, if changed since
last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: |
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common
Stock, $0.01 par value |
|
UAMY |
|
NYSE
American |
| Common
Stock, $0.01 par value |
|
UAMY |
|
NYSE
Texas |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 7.01 Regulation FD Disclosure.
On January 28, 2026, United States Antimony Corporation
(NYSE: UAMY) (NYSE Texas:UAMY) (“USAC,” “US Antimony,” or the “Company”) issued a press release (“Press
Release”) announcing it has been involved since mid-2025 in funding and assisting with the development of a new hydrometallurgical
(hydromet) processing facility for refining antimony and other critical minerals on a commercial scale associated with a project located
in the country of Bolivia.
The foregoing disclosure is qualified in its entirety
by the full text of the Press Release.
A copy of the Press Release is attached as Exhibit
99.1 and is hereby incorporated by reference into this Item 7.01. The information contained in this Current Report on Form 8-K, including
Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed” for any purpose, including for the purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that Section and shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933,
as amended, regardless of any general incorporation language in such filing, except to the extent expressly stated in such filing.
Cautionary Note Regarding Forward-Looking Statements
This Current Report on Form 8-K, including the
Press Release, contains forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, judgment,
and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements
are reasonable, they give no assurance that such expectations will prove to be correct, and you should be aware that actual events or
results may differ materially from those contained in the forward- looking statements. Words such as "will," "expect,"
"intend," "plan," "potential," "possible," "goals," "accelerate," "continue,"
and similar expressions identify forward-looking statements.
Forward-looking statements are subject to a number
of risks and uncertainties including, but not limited to, those described in the Company’s filings on Form 10-K, Form 10-Q, and
Form 8-K with the United States Securities and Exchange Commission.
All forward-looking statements are expressly qualified
in their entirety by this cautionary notice. You should not rely upon any forward-looking statements as predictions of future events.
The Company undertakes no obligation to revise or update any forward-looking statements made in this Current Report on Form 8-K to reflect
events or circumstances after the date hereof, to reflect new information or the occurrence of unanticipated events, to update the reasons
why actual results could differ materially from those anticipated in the forward-looking statements, in each case, except as required
by law.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
|
Description |
| 99.1 |
|
Press
Release issued by United States Antimony Corporation dated January 28, 2026 |
| 104 |
|
Cover Page Interactive Data File (embedded with the inline XBRL document) |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
UNITED STATES ANTIMONY CORPORATION |
| |
|
| Dated: January 28, 2026 |
By: |
/s/ Richard R. Isaak |
| |
Richard R. Isaak |
| |
SVP, Chief Financial Officer |